Ben Taub Hospital
Houston, Texas, 77030, United States
NCT Number: NCT05975385
The purpose is to find out if intraoperative acupuncture performed by needling PC 6 and LI4 point bilaterally, and Yin Tang point will help reduce the incidence postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when added to a prophylactic regimen consisting of ondansetron and dexamethasone. The hypothesis is that the addition of this acupuncture treatment to ondansetron and dexamethasone given for prophylaxis will help reduce the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when compared to patients receiving ondansetron and dexamethasone without acupuncture.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Acupuncture at points points PC 6 bilaterally, LI 4 bilaterally, and Yin Tang
Time frame: Postoperative: 0-1 hours, 1-6 hours, 6-12 hours, 12-24 hours
Incidence of nausea and vomiting after surgery
Time frame: 24 hours
Pain on scale 1-10 measured on arrival to PACU, discharge from PACU and at 24 hours post surgery
Time frame: 24 hours
Total opioid given, converted to oral morphine equivalents
Baylor College of Medicine
Other
Acupuncture For Prevention Of Postoperative Nausea And Vomiting In Patients Undergoing Laparoscopic Cholecystectomy - A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06244589
Biliary Tract Diseases, Bronchial Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07672145
Biliary Tract Diseases, Cholecystitis
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07649811
Biliary Tract Diseases, Cholecystitis
Xi'an, Shaanxi, China
View Trial DetailsNCT06656299
Biliary Tract Diseases, Bronchial Diseases
Istanbul, Turkey (Türkiye)
View Trial Details